Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036637 | SCV000060292 | likely benign | not specified | 2012-09-21 | criteria provided, single submitter | clinical testing | Lys259Glu in exon 10 of TPM1: This variant is not expected to have clinical sign ificance because it has been identified in 1.6% (3/186) of Finnish chromosomes b y the 1000 genomes project (rs144045691). At this frequency it is unlikely disea se causing though a modifying role cannot be excluded. Lys259Glu in exon 10 of TPM1 (rs144045691; allele frequency = 1.6%, 3/186) |
Gene |
RCV001701646 | SCV000209338 | likely benign | not provided | 2019-01-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23785128, 28798025, 30847666) |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000036637 | SCV000747942 | uncertain significance | not specified | 2017-07-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001176802 | SCV001340859 | benign | Cardiomyopathy | 2018-06-18 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000143960 | SCV000188841 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2013-11-19 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000036637 | SCV001920049 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701646 | SCV001927983 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701646 | SCV001952935 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003952419 | SCV004785312 | benign | TPM1-related disorder | 2019-08-19 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |